Related Experiment Video
Updated: May 11, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
The relation between stone disease and obesity in Jordan
Lara Alex Abu Ghazaleh1, Zahran Budair
1Urology Department, Royal Medical Services, Amman, Jordan. lulalex@hotmail.com
Summary
Obesity is linked to kidney stones in Jordan. Over 68% of patients with urolithiasis were overweight or obese, indicating a significant association between excess weight and stone formation in this population.
Area of Science:
- Urology
- Public Health
- Nephrology
Background:
- Obesity is a global health concern with significant prevalence in Jordan.
- A known correlation exists between obesity and the development of renal stones (urolithiasis).
Purpose of the Study:
- To investigate the relationship between obesity and renal stone formation in the Jordanian population.
- To analyze the characteristics of urolithiasis patients in Jordan concerning their body weight.
Main Methods:
- Retrospective analysis of 8346 urolithiasis patients treated between January 2006 and January 2011.
- Data collected included age, gender, body weight (categorized by BMI), clinic visits, and surgical procedures.
- Patients were classified as normal weight, overweight (BMI >25 kg/m²), or obese (BMI >30 kg/m²).
Main Results:
- The majority of urolithiasis patients (68.1%) were either overweight or obese.
- Obese patients (42.3%) and overweight patients (25.8%) constituted a significant portion of the study cohort.
- Obese and overweight individuals experienced more clinical visits and surgical procedures compared to normal-weight patients.
Conclusions:
- A clear association between obesity and renal stone formation is evident in the Jordanian population.
- Higher rates of urolithiasis are observed in overweight and obese individuals, underscoring the impact of weight management on kidney stone prevention.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:26Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...